BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

CIL is Now Offering Cannabis Standards for MS-based Testing

Research suggests the cannabis plant produces between 80-100 cannabinoids, primarily cannabidiol (CBD) and tetrahydrocannabinol (THC). The complexity and d...

September 01, 2021 | News

Poseida announces FDA clearance of IND for its first fully CAR-T therapy for patients with multiple myeloma.

Poseida Therapeutics, Inc. , a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell ...

August 30, 2021 | News

Merck’s KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has received two new ...

August 30, 2021 | News

Insilico Medicine & 4B Technologies to advance the development of innovative small molecule therapies

Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery company, and 4B Technologies Co., Ltd. ("4B ...

August 30, 2021 | News

Pharmac to fund new cardiovascular medicine with amended Special Authority criteria

People with at high-risk of cardiovascular disease, who meet the funding criteria, will be able to access funded rosuvastatin from 1 December 2021. &ldquo...

August 29, 2021 | News

Kintor Pharma Collaborates with Etana to Commercialize Proxalutamide to treat Covid19

Pursuant to the Licensing Agreement, Kintor Pharma will receive from Etana upfront and milestone payments, in addition to the economic benefit relating to ...

August 26, 2021 | News

ExoCoBio to Build the World’s First Clinical Grade Exosome GMP Manufacturing Facility

ExoCoBio will invest approximately US $20M to build the EGMP facility whose project actually started in 2019, and after two years of intensive ...

August 26, 2021 | News

Elekta to address Indonesia's cancer care gap with direct presence

Elekta (EKTA-B.ST) announced today that is has established permanent legal entity in Indonesia's capital, Jakarta in order to address t...

August 25, 2021 | News

Daewoong Pharma, Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics

Daewoong Pharmaceutical and Hanall Biopharma of South Korea are expanding their global open collaboration initiative by investing in Alloplex Bio...

August 20, 2021 | News

Senhwa's Silmitasertib Receives US FDA Fast Track Designation

Senhwa Biosciences, Inc., a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today ann...

August 19, 2021 | News

HDT Bio ,Korea’s Quratis to Co-Develop COVID-19 Vaccine in Asia

HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced today an agreement with Korean biotech Quratis Inc. to co-dev...

August 18, 2021 | News

SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline

PlexPrime® SARS-CoV-2 P681R Delta is a single well research mix designed to detect the P681R spike mutation of SARS-CoV-2 found in B.1.617.2 (Delta) VO...

August 18, 2021 | News

FDA Grants Emergency Use Authorization for Two Next-Generation COVID-19 Assays from Thermo Fisher Scientific

Both PCR-based kits leverage an updated design from the original TaqPath assays, targeting eight different genes across three regions of the virus that cau...

August 17, 2021 | News

InferVision AI Assists the EU Monitoring COVID-19 Variants

InferVision's AI applications have been developed to assist clinicians by quickly and accurately analyzing signs of pulmonary infections from regular chest...

August 17, 2021 | News

Stay Connected